1,152 material Form 8-K filings that 918 companies we cover made with the SEC in October 2025, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
H2O America reported third-quarter 2025 results on October 27, 2025, with GAAP net income of $45.1 million, up 17% from $38.7 million a year earlier, and revenue of $240.6 million, up 7% from $225.1 million. The company narrowed its 2025 adjusted diluted EPS guidance to $2.95 to $3.00 from $2.90 to $3.00, and declared a $0.42 quarterly dividend. Shareholders get higher reported earnings and a narrower guidance range, while the pending Quadvest acquisition still awaits regulatory approval.
Q3 2025 GAAP net income was $45.1 million, up 17% from $38.7 million; revenue was $240.6 million, up 7% from $225.1 million
Q3 adjusted diluted EPS was $1.27 versus $1.18 a year earlier, an 8% increase; GAAP diluted EPS was $1.27 versus $1.17
2025 adjusted diluted EPS guidance narrowed to $2.95 to $3.00, the upper half of the original $2.90 to $3.00 range
Quarterly dividend of $0.42 per share, payable December 1, 2025, to holders of record on November 10, 2025
Polaris reported third quarter 2025 sales of $1,842 million, up 7% from a year earlier, but posted a reported net loss attributable to Polaris of $16 million, or $0.28 per diluted share, compared with net income of $28 million, or $0.49 per share, a year earlier. The loss reflected a $42.3 million non-cash impairment charge in the On Road segment, while adjusted diluted EPS fell 44% to $0.41. The company also reintroduced its full-year 2025 guidance, expecting adjusted sales of $6.9 billion to $7.1 billion and adjusted EPS of about negative $0.05.
Third quarter sales were $1,842 million, up 7%; North America sales rose 8% to $1,586 million.
Reported diluted loss per share was $0.28 versus $0.49 income a year earlier; adjusted diluted EPS was $0.41, down 44%.
A $42.3 million non-cash impairment charge related to On Road property and equipment was recorded in the quarter.
2025 guidance was reintroduced: adjusted sales of $6.9 billion to $7.1 billion and adjusted EPS of about ($0.05).
Crane Company reported third quarter 2025 GAAP EPS from continuing operations of $1.56, up 25%, and adjusted EPS of $1.64, up 27%, on sales of $589.2 million, up 7.5%. The company raised and narrowed its full-year adjusted EPS outlook to $5.75-$5.95 from $5.50-$5.80, which management said reflects 20% growth at the midpoint over 2024.
Q3 2025 GAAP EPS from continuing operations was $1.56 versus $1.25 a year earlier; adjusted EPS was $1.64 versus $1.29.
Net sales were $589.2 million, up 7.5%, including 5.6% core sales growth; backlog was $1,437.1 million at September 30, 2025.
Full-year adjusted EPS outlook raised to $5.75-$5.95 from $5.50-$5.80; the company declared a fourth quarter dividend of $0.23 per share.
Fox Factory entered into a Fifth Amendment to its credit agreement on October 24, 2025, with Wells Fargo as administrative agent, replacing existing loans with a $537.5 million term loan, a $500.0 million revolver and up to $175.0 million of incremental capacity. The company borrowed $710 million under the amended agreement and used it to repay all prior amounts owed, with the facilities due October 24, 2030.
Borrowed $710 million: $537.5 million term loan plus $172.5 million under the $500.0 million revolving credit facility
Facilities mature October 24, 2030; term loan repaid in quarterly installments of $6,718,750
Maximum Consolidated Net Leverage Ratio set at 4.50 through January 2, 2026, stepping down to 4.00 from July 3, 2026
Interest on SOFR loans set at a margin of 1.00% to 2.50%
NETSTREIT reported third quarter 2025 results, with net income of $0.01 per diluted share against a loss of $0.07 a year earlier, and AFFO of $0.33 per diluted share, up from $0.32. The company kept its full-year 2025 AFFO per share guidance of $1.29 to $1.31 and raised its net investment guidance to $350.0 million to $400.0 million from $125.0 million to $175.0 million.
Q3 2025 AFFO per diluted share was $0.33, up 3.1% from $0.32; FFO per diluted share fell 9.4% to $0.29 and Core FFO fell 3.1% to $0.31
Gross investment activity was $203.9 million at a 7.4% blended cash yield in the quarter
Full-year 2025 net investment guidance raised to $350.0 million to $400.0 million; AFFO per share guidance maintained at $1.29 to $1.31
Board declared a quarterly dividend of $0.215 per share, payable December 15, 2025 to holders of record on December 1, 2025
Everest Group entered into two adverse development reinsurance agreements, dated October 26, 2025 and effective October 1, 2025, that cover future reserve development on its North American Insurance business for accident years 2024 and prior, with a $1.2 billion gross limit. The company will pay consideration at closing, and its press release says the approximately $122 million payment will be reported as an incurred loss in the fourth quarter of 2025, which affects shareholders through a near-term charge. The deal is intended to limit further reserve risk on its US Casualty portfolio, while Everest keeps authority to handle and resolve claims.
Agreements with State National Insurance Company and MS Transverse Insurance Company are dated October 26, 2025, and effective October 1, 2025.
Cover provides $1.2 billion of gross limit against future adverse reserve development on North American Insurance business, supported by Longtail Re.
State National consideration is $250 million Funds Withheld and $1.0 billion of transferred assets; MS Transverse consideration is $122 million of transferred assets.
Everest retains $100 million of co-participation in each layer, and the $122 million payment is to be reported as an incurred loss in Q4 2025.
Simpson Manufacturing reported third-quarter 2025 net sales of $623.5 million, up 6.2%, and diluted EPS of $2.58, up 16.7%, with operating income boosted by a $12.9 million gain on the sale of its Gallatin, Tennessee facility. The company updated its full-year 2025 outlook and announced cost-saving initiatives expected to yield about $30 million in annualized savings, with one-time charges of $9.0 million to $12.0 million in 2025.
Net sales of $623.5 million rose 6.2%; diluted EPS of $2.58 rose from $2.21 a year earlier.
Income from operations of $140.7 million rose 12.7%, including the $12.9 million Gallatin facility sale benefit.
2025 outlook: consolidated operating margin of 19.0% to 20.0% and capital expenditures of $150.0 million to $160.0 million.
Board authorized up to $150.0 million in share repurchases for 2026 and declared a $0.29 quarterly dividend.
Agilent Technologies appointed Adam S. Elinoff, currently vice president of investor relations and treasurer at Amgen, as senior vice president and chief financial officer effective November 17, 2025, replacing interim CFO Rodney Gonsalves, who remains corporate controller and principal accounting officer. The filing discloses a compensation package including a $700,000 base salary, equity awards, and an $800,000 one-time cash bonus, which matters to shareholders as a change in the leader of the company's finance function.
Adam S. Elinoff, age 48, becomes CFO effective November 17, 2025, succeeding Rodney Gonsalves, who has been interim CFO since July 31, 2025.
Elinoff's base salary is $700,000, with bonus eligibility of 80% of base salary.
Equity awards include $1,100,000 in fiscal 2025 RSUs, $1,650,000 in performance-based RSUs for fiscal 2026 to 2028, and sign-on grants of $560,000 in RSUs and $840,000 in performance-based RSUs.
A one-time $800,000 cash bonus is subject to repayment if he leaves within twelve months.
Everest Group reported third quarter 2025 net income of $255 million, or $6.09 per diluted share, down from $509 million, or $11.80 per diluted share, a year earlier. The group combined ratio rose to 103.4% from 93.1%, driven by $478 million of unfavorable prior-year reserve development, including $361 million of U.S. casualty reserve strengthening in the Insurance segment. The company also entered an adverse development cover and agreed to sell its retail commercial insurance renewal rights to AIG, which it expects to result in a pre-tax non-operating charge of $250 million to $350 million.
Net operating income was $316 million, or $7.54 per diluted share, versus $630 million, or $14.62 per diluted share, in Q3 2024.
Group combined ratio was 103.4% versus 93.1%; Insurance segment combined ratio was 138.1%.
Gross written premium was $4.4 billion, down 1.2% on a comparable basis from a year earlier.
Expected pre-tax non-operating charge of $250 million to $350 million on the AIG renewal rights sale, recognized over 2025 and 2026.
Kilroy Realty reported third-quarter 2025 revenue of $279.7 million, down from $289.9 million a year earlier, and FFO of $130.6 million, or $1.08 per diluted share, versus $140.4 million, or $1.17, a year earlier. Net income available to common stockholders rose to $156.2 million, or $1.31 per diluted share, from $52.4 million, or $0.44, a year earlier, with the filing citing $110.5 million of gains on property sales. The company raised its full-year 2025 FFO per diluted share guidance to $4.18-$4.24 from $4.05-$4.15.
Q3 2025 revenue of $279.7 million, versus $289.9 million in Q3 2024
FFO of $130.6 million, or $1.08 per diluted share, versus $140.4 million, or $1.17, a year earlier
Net income available to common stockholders of $156.2 million, or $1.31 per diluted share, including $110.5 million of gains on sales of depreciable operating properties
Full-year 2025 FFO per diluted share guidance raised to $4.18-$4.24 from $4.05-$4.15; earnings call scheduled for October 28, 2025
F5 reported fiscal fourth-quarter 2025 revenue of $810 million, up 8% year over year, and GAAP diluted EPS of $3.26 versus $2.80, with non-GAAP diluted EPS of $4.39 versus $3.67. For fiscal 2026 the company guided to revenue growth of 0% to 4% and non-GAAP EPS of $14.50 to $15.50, citing expected sales-cycle disruption after a recent security incident, and said CEO François Locoh-Donou will become Board Chair in March 2026.
Q4 FY2025 revenue was $810 million, up 8%; systems revenue rose 42% and software revenue rose 0.3%.
Q4 non-GAAP diluted EPS was $4.39, up from $3.67; GAAP diluted EPS was $3.26, up from $2.80.
FY2026 guidance: total revenue growth of 0% to 4%, versus 10% growth in FY2025, and non-GAAP EPS of $14.50 to $15.50, versus $15.81 in FY2025.
Locoh-Donou will succeed Alan J. Higginson as Chair at the Annual Meeting expected in March 2026.
Whirlpool reported third-quarter 2025 net sales of $4.03 billion, up 1.0% from a year earlier, but GAAP earnings per diluted share fell to $1.29 from $2.00 and ongoing EPS fell to $2.09 from $3.43. The company narrowed its full-year outlook to GAAP EPS of about $6.00 and ongoing EPS of about $7.00, and revised operating cash flow to about $600 million and free cash flow to about $200 million.
Q3 net sales were $4,033 million versus $3,993 million, up 1.0%; ongoing EBIT fell 22.7% to $180 million.
GAAP net earnings available to Whirlpool were $73 million versus $109 million a year earlier, down 33.3%.
A non-cash loss of $14 million, or $0.24 per diluted share, from Beko Europe B.V. equity in affiliates weighed on Q3 results.
The company declared a Q4 dividend of $0.90 per share and expects full-year free cash flow of about $200 million.
Amkor reported third-quarter 2025 net sales of $1.99 billion, up from $1.86 billion a year earlier, with net income of $127 million and diluted EPS of $0.51 versus $0.49 in the prior-year quarter. The company also said CEO Giel Rutten will retire on December 31, 2025, and that Chief Operating Officer Kevin Engel will succeed him, with Rutten remaining on the board and Engel joining it. Fourth-quarter guidance calls for net sales of $1.775 billion to $1.875 billion and diluted EPS of $0.38 to $0.48.
Q3 2025 net sales $1.99 billion, up 31% from Q2 2025 and up from $1.86 billion in Q3 2024; net income $127 million, diluted EPS $0.51
Q4 2025 guidance: net sales of $1.775 billion to $1.875 billion; net income of $95 million to $120 million, or $0.38 to $0.48 per diluted share
Kevin Engel to become President and CEO effective January 1, 2026, with a starting base salary of $900,000 and a target bonus of 125% of salary
Rutten will advise the company through March 31, 2026, then join the board as a non-employee director beginning April 1, 2026
Alexandria Real Estate Equities reported a third-quarter 2025 net loss attributable to common stockholders of $234.9 million, or $1.38 per diluted share, compared with net income of $164.7 million, or $0.96 per share, a year earlier. The company lowered the midpoint of its 2025 funds from operations (FFO) per share, as adjusted, guidance by 25 cents to $9.01, and cut its 2025 net loss per share guidance midpoint by $3.44 to $(2.94), which matters to shareholders because it reflects weaker expected operating results and larger asset write-downs.
Q3 2025 net loss of $234.9 million, or $(1.38) per diluted share, versus net income of $164.7 million, or $0.96 per share, in Q3 2024.
Q3 2025 FFO per share, as adjusted, of $2.22, down from $2.37 a year earlier; year-to-date FFO per share, as adjusted, was $6.85 versus $7.08.
2025 FFO per share, as adjusted, guidance midpoint lowered to $9.01 from $9.26, citing slower re-leasing and reduced life science demand.
Year-to-date impairments of real estate of $485.6 million; potential additional 4Q25 impairments ranging from $0 to $685 million.
VSE Corporation reported third-quarter 2025 revenue of $282.9 million, up 38.9% from a year earlier, while GAAP net income fell 58.9% to $3.6 million, partly due to a $23.3 million earn-out receivable fair value adjustment. The company raised its full-year 2025 revenue growth and Aviation Adjusted EBITDA margin guidance and said it signed a definitive agreement to acquire Aero 3.
Q3 2025 revenue of $282.9 million, up 38.9%; GAAP diluted EPS of $0.17, down 63.8%
Adjusted diluted EPS of $0.99, up 86.8%; Adjusted EBITDA of $47.4 million, up 58.4%
Full-year 2025 revenue growth guidance raised to 38% to 40%, from 35% to 40%; Aviation Adjusted EBITDA margin guidance raised to 17.0% to 17.25%, from 16.5% to 17%
Definitive agreement to acquire GenNx/AeroRepair IntermediateCo Inc., parent of Aero 3; the filing does not state a purchase price
Talen Energy Supply, LLC, a wholly owned subsidiary of Talen Energy Corporation, completed private offerings of $1.40 billion of 6.250% notes due 2034 and $1.29 billion of 6.500% notes due 2036 on October 27, 2025. The proceeds, together with a new $1.2 billion senior secured term loan B, are intended to fund the acquisitions of the Freedom Energy Center in Pennsylvania and the Guernsey Power Station in Ohio. If one or both acquisitions are not completed by the outside date, the company must redeem the notes in specified amounts, which makes the debt contingent on those deals closing.
$1.40 billion of 6.250% senior notes due February 1, 2034 and $1.29 billion of 6.500% senior notes due February 1, 2036 were issued
Interest is payable semi-annually, beginning August 1, 2026
Freedom Energy Center (1,045 MW, Luzerne County, Pennsylvania) and Guernsey Power Station (1,836 MW, Guernsey County, Ohio) are being acquired from affiliates of Caithness Energy, L.L.C.
Mandatory redemption applies if acquisitions are not completed by the July 17, 2026 outside date, or January 17, 2027 if extended
Northwest Bancshares reported third quarter 2025 GAAP net income of $3 million, or $0.02 per diluted share, down from $34 million, or $0.26, in both the prior quarter and the year-earlier quarter. The decline reflects $31 million of merger, asset disposition and restructuring expense tied to the Penns Woods Bancorp acquisition, which closed on July 25, 2025, while total revenue reached a record $168 million, up 21% year over year. The company also declared a $0.20 quarterly dividend.
Q3 2025 GAAP net income of $3 million, or $0.02 per diluted share, versus $34 million, or $0.26, in Q2 2025 and Q3 2024
Adjusted net income (non-GAAP) of $41 million, or $0.29 per diluted share, up from $38 million, or $0.30, in Q2 2025
Record total revenue of $168 million, up 21% year over year; net interest margin of 3.65%
Quarterly cash dividend of $0.20 per share, payable November 18, 2025, to shareholders of record as of November 6, 2025
Brixmor reported third-quarter 2025 revenue of $340.8 million, up from $320.7 million a year earlier, and Nareit FFO of $0.56 per diluted share, up from $0.52. GAAP net income per diluted share slipped to $0.31 from $0.32, and the company raised the low end of its 2025 Nareit FFO guidance to $2.23-$2.25. The company also raised its quarterly dividend 7.0% and disclosed that CEO James M. Taylor is on temporary medical leave, with President and COO Brian T. Finnegan serving as interim CEO.
Q3 2025 total revenues were $340.8 million, versus $320.7 million in Q3 2024; Nareit FFO was $172.3 million, or $0.56 per diluted share, versus $0.52
Q3 2025 net income attributable to Brixmor was $94.2 million, or $0.31 per diluted share, versus $0.32 a year earlier
2025 Nareit FFO per diluted share guidance is now $2.23-$2.25, up from $2.22-$2.25; same property NOI growth guidance of 3.90%-4.30% was affirmed
Quarterly dividend increased 7.0% to $0.3075 per share, payable January 15, 2026; Brian T. Finnegan became interim CEO effective October 16, 2025
Agilysys reported fiscal 2026 second-quarter revenue of $79.3 million, up 16.1% from $68.3 million a year earlier, and net income of $11.7 million, or $0.41 per diluted share, versus $1.4 million, or $0.05, in the prior-year quarter. The company raised its full-year fiscal 2026 revenue guidance to $315 million to $318 million and its subscription revenue growth expectation to 29% from 27%, while keeping adjusted EBITDA expectations at 20% of revenue.
Total net revenue rose 16.1% to a record $79.3 million; subscription revenue grew 33.1%.
Net income was $11.7 million, or $0.41 per diluted share, compared with $1.4 million, or $0.05, a year earlier.
Full-year fiscal 2026 revenue guidance raised to $315 million to $318 million; subscription growth expectation raised to 29% from 27%.
Gross margin was 61.7%, down from 63.3%; adjusted EBITDA was $16.4 million, up from $12.2 million.
Park National Corporation signed a merger agreement with First Citizens Bancshares, under which each First Citizens share would convert into 0.52 of a Park common share, with closing expected in the first quarter of 2026 subject to regulatory and First Citizens shareholder approvals. The same day, Park reported third-quarter 2025 net income of $47.2 million, up 23.4% from a year earlier, and diluted earnings per share of $2.92 versus $2.35.
Merger terms: each First Citizens common share converts into 0.52 of a Park common share; closing expected in the first quarter of 2026.
A $12.5 million termination fee is payable by First Citizens to Park in certain circumstances.
Q3 2025 net income was $47.2 million, up 23.4%; diluted EPS was $2.92 versus $2.35.
Park declared a quarterly dividend of $1.07 and a special one-time dividend of $1.25 per share, payable December 10, 2025.
Cadence reported third-quarter 2025 revenue of $1.339 billion, up from $1.215 billion a year earlier, and non-GAAP diluted earnings of $1.93 per share, up from $1.64. The company raised its full-year 2025 revenue and non-GAAP EPS outlook, and reported a record backlog of $7.0 billion, which points to stronger expected results for shareholders.
Q3 2025 revenue $1.339 billion vs $1.215 billion in Q3 2024; GAAP diluted EPS $1.05 vs $0.87
Non-GAAP diluted EPS $1.93 vs $1.64 in Q3 2024
FY 2025 revenue outlook raised to $5.262 billion–$5.292 billion from $5.210 billion–$5.270 billion; non-GAAP EPS outlook raised to $7.02–$7.08 from $6.85–$6.95
Organon CEO Kevin Ali resigned on October 26, 2025, as CEO and board member in connection with an Audit Committee investigation into wholesaler sales practices for Nexplanon. Joseph Morrissey was named interim CEO, and Chair Carrie Cox became interim Executive Chair. The company says the findings do not require a restatement, but it has concluded that its prior internal control assessment and auditor's opinion for 2024 should no longer be relied upon.
Kevin Ali resigned as CEO and director on October 26, 2025, and will not receive severance or equity-related retirement benefits.
Joseph Morrissey, Executive Vice President and Head of Manufacturing & Supply, was appointed interim CEO with a $1 million salary, a 100% bonus target, a $4 million long-term incentive target next year, and a one-time $1 million RSU grant.
Investigation found Nexplanon wholesaler purchases in several 2022, 2024 and 2025 periods, which were under 1% of annual consolidated revenue and helped meet guidance or external revenue expectations.
The company expects to file an amended 2024 Form 10-K and amended Forms 10-Q for the first two 2025 quarters, and a third quarter 2025 10-Q by the SEC deadline.
Albemarle agreed to sell a controlling stake in Ketjen's refining catalyst business to KPS Capital Partners and to sell its 50% stake in the Eurecat joint venture to Axens SA. The company expects total pre-tax cash proceeds of about $660 million, and it will record a non-cash goodwill impairment charge of $181.5 million in the third quarter of 2025. Both transactions are expected to close in the first half of 2026, subject to regulatory approvals.
Albemarle expects to receive an estimated $536 million in cash from the KPS transaction and about $660 million in total pre-tax proceeds across both deals
Non-cash goodwill impairment charge of $181.5 million in Q3 2025, covering the full goodwill of the Refining Solutions reporting unit
Albemarle will keep an approximately 49% stake in Ketjen and retain the Performance Catalyst Solutions business, including the Pasadena, Texas plant
Both transactions are expected to close in the first half of 2026; either party may terminate if not closed by April 30, 2026
Revvity reported third-quarter 2025 results on October 27, 2025. Revenue rose to $699 million from $684 million, but GAAP EPS fell to $0.40 from $0.77 and adjusted EPS fell to $1.18 from $1.28. The company raised its full-year 2025 adjusted EPS guidance to $4.90 to $5.00 and authorized a new two-year $1 billion share repurchase program.
Q3 revenue was $699 million vs. $684 million a year earlier, up 2% reported and 1% organic.
Q3 adjusted EPS was $1.18 vs. $1.28; GAAP EPS was $0.40 vs. $0.77.
Full-year 2025 adjusted EPS guidance raised to $4.90 to $5.00; revenue guidance updated to $2.83 to $2.88 billion; organic growth guidance of 2% to 4% reaffirmed.
New two-year $1 billion share repurchase program replaces the remainder of the program announced in October 2024.
On October 26, 2025, Essential Utilities agreed to merge into a subsidiary of American Water Works, with Essential surviving as a wholly owned subsidiary of American Water. Each Essential share would convert into 0.305 shares of American Water common stock, and the companies say the ratio implies a premium of approximately 10% to Essential shareholders. The deal requires approval from both companies' shareholders and regulatory clearances, and it is expected to close by the end of the first quarter of 2027.
Each Essential common share converts into 0.305 American Water shares; the press release cites a premium of about 10% based on the 60-trading-day VWAP ending October 24, 2025.
After closing, American Water shareholders would own about 69% and Essential shareholders about 31% of the combined company on a fully diluted basis.
Essential would pay American Water a $370 million termination fee, or American Water would pay Essential $835 million, under specified circumstances.
The transaction is expected to close by the end of the first quarter of 2027, subject to shareholder, Hart-Scott-Rodino and public utility commission approvals.
American Water and Essential Utilities agreed on October 26, 2025 to combine, with Essential becoming a wholly owned subsidiary of American Water. Essential shareholders would receive 0.305 American Water shares for each Essential share, and the deal is expected to close by the end of the first quarter of 2027 after shareholder, antitrust and utility commission approvals.
Exchange ratio of 0.305 American Water shares per Essential share, which the companies say implies a premium of about 10%.
Pro forma ownership of about 69% for American Water shareholders and 31% for Essential shareholders, with a combined market capitalization of about $40 billion.
Termination fees of $370 million payable by Essential or $835 million payable by American Water in specified circumstances.
Expected close by the end of the first quarter of 2027; the merger requires shareholder approvals and regulatory clearances.
Keurig Dr Pepper reported third-quarter 2025 net sales of $4.3 billion, up 10.7% from a year earlier, and GAAP diluted EPS of $0.49, up 8.9%. The company raised its full-year 2025 constant currency net sales growth outlook to a high-single-digit range from mid-single-digit, and reaffirmed its adjusted EPS growth outlook of high-single-digit.
Q3 2025 net sales were $4.3 billion, up 10.7%; constant currency net sales rose 10.6%
GAAP diluted EPS was $0.49, up 8.9%; adjusted diluted EPS was $0.54, up 5.9%
Full-year 2025 constant currency net sales growth outlook raised to high-single-digit from mid-single-digit
Adjusted diluted EPS growth outlook of high-single-digit reaffirmed
Carter's reported third-quarter fiscal 2025 net sales of $757.8 million, roughly flat versus a year earlier, while operating income fell to $29.1 million from $77.0 million and diluted EPS fell to $0.32 from $1.62. The company suspended its fiscal 2025 guidance because of tariff uncertainty and approved an organizational restructuring plan with $10.1 million to $11.1 million in total charges, which it says will reduce costs and improve future profitability.
Q3 net sales $757.8 million, down 0.1% from $758.5 million; U.S. Retail comparable net sales up 2.0%
Q3 operating income $29.1 million vs. $77.0 million; diluted EPS $0.32 vs. $1.62; adjusted diluted EPS $0.74 vs. $1.64
Fiscal 2025 guidance suspended; Q4 net adverse pre-tax impact from additional tariffs estimated at $25 million to $35 million
Restructuring plan approved September 16, 2025 to cut about 300 office roles (15%) by end of 2025; about $35 million annualized savings expected from 2026
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.